| Dr Michael Elliott, MD | |
|
2150 Pennsylvania Ave Nw, Washington, DC 20037 | |
| (202) 741-2222 | |
| Not Available |
| Full Name | Dr Michael Elliott |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 9 Years |
| Location | 2150 Pennsylvania Ave Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790164127 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | MD2021-1123 (New Mexico) | Primary |
| 208M00000X | Hospitalist | MTL003210 (District Of Columbia) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lovelace Medical Center | Albuquerque, NM | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southwest Medical Associates, Llc | 7214831114 | 291 |
News Archive
Conatus Pharmaceuticals Inc. announced today the treatment of the first patient in a multi-center Phase 2b clinical trial evaluating CTS-1027 in combination with Peginterferon Alfa-2a and ribavirin in a treatment experienced, hepatitis C null responder patient population. Safety, tolerability, and antiviral activity of the triple combination will be assessed after up to 48 weeks of therapy.
With the increasing production of electronic products in the consumer market, more button batteries are found in the home setting. From remote controls and watches to musical greeting cards and toys, these small, shiny objects are the perfect size for a curious child to swallow or even push into their nasal cavity or ear canal. It is important for parents to be aware of the dangers that button batteries pose to young children and the damage that these batteries can cause.
New research into the cost of using the breast cancer drug Herceptin warns that healthcare authorities and the organisations advising them should not rush to prescribe it for early breast cancer without working out extremely carefully the budget implications and cost-effectiveness of the drug.
Doctors know patients with atrial fibrillation are at a higher risk of having a stroke, and now a new study finds that integrating two separate clinical risk score models helps clinicians more accurately assess the stroke risk of patients with Afib.
› Verified 2 days ago
| Entity Name | Southwest Medical Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164491072 PECOS PAC ID: 7214831114 Enrollment ID: O20031121000724 |
News Archive
Conatus Pharmaceuticals Inc. announced today the treatment of the first patient in a multi-center Phase 2b clinical trial evaluating CTS-1027 in combination with Peginterferon Alfa-2a and ribavirin in a treatment experienced, hepatitis C null responder patient population. Safety, tolerability, and antiviral activity of the triple combination will be assessed after up to 48 weeks of therapy.
With the increasing production of electronic products in the consumer market, more button batteries are found in the home setting. From remote controls and watches to musical greeting cards and toys, these small, shiny objects are the perfect size for a curious child to swallow or even push into their nasal cavity or ear canal. It is important for parents to be aware of the dangers that button batteries pose to young children and the damage that these batteries can cause.
New research into the cost of using the breast cancer drug Herceptin warns that healthcare authorities and the organisations advising them should not rush to prescribe it for early breast cancer without working out extremely carefully the budget implications and cost-effectiveness of the drug.
Doctors know patients with atrial fibrillation are at a higher risk of having a stroke, and now a new study finds that integrating two separate clinical risk score models helps clinicians more accurately assess the stroke risk of patients with Afib.
› Verified 2 days ago
| Entity Name | Daiya Healthcare Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477027381 PECOS PAC ID: 6002158615 Enrollment ID: O20200903001256 |
News Archive
Conatus Pharmaceuticals Inc. announced today the treatment of the first patient in a multi-center Phase 2b clinical trial evaluating CTS-1027 in combination with Peginterferon Alfa-2a and ribavirin in a treatment experienced, hepatitis C null responder patient population. Safety, tolerability, and antiviral activity of the triple combination will be assessed after up to 48 weeks of therapy.
With the increasing production of electronic products in the consumer market, more button batteries are found in the home setting. From remote controls and watches to musical greeting cards and toys, these small, shiny objects are the perfect size for a curious child to swallow or even push into their nasal cavity or ear canal. It is important for parents to be aware of the dangers that button batteries pose to young children and the damage that these batteries can cause.
New research into the cost of using the breast cancer drug Herceptin warns that healthcare authorities and the organisations advising them should not rush to prescribe it for early breast cancer without working out extremely carefully the budget implications and cost-effectiveness of the drug.
Doctors know patients with atrial fibrillation are at a higher risk of having a stroke, and now a new study finds that integrating two separate clinical risk score models helps clinicians more accurately assess the stroke risk of patients with Afib.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Elliott, MD 4101 Indian School Rd Ne, Ste 110, Albuquerque, NM 87110-3991 Ph: (505) 727-8360 | Dr Michael Elliott, MD 2150 Pennsylvania Ave Nw, Washington, DC 20037 Ph: (202) 741-2222 |
News Archive
Conatus Pharmaceuticals Inc. announced today the treatment of the first patient in a multi-center Phase 2b clinical trial evaluating CTS-1027 in combination with Peginterferon Alfa-2a and ribavirin in a treatment experienced, hepatitis C null responder patient population. Safety, tolerability, and antiviral activity of the triple combination will be assessed after up to 48 weeks of therapy.
With the increasing production of electronic products in the consumer market, more button batteries are found in the home setting. From remote controls and watches to musical greeting cards and toys, these small, shiny objects are the perfect size for a curious child to swallow or even push into their nasal cavity or ear canal. It is important for parents to be aware of the dangers that button batteries pose to young children and the damage that these batteries can cause.
New research into the cost of using the breast cancer drug Herceptin warns that healthcare authorities and the organisations advising them should not rush to prescribe it for early breast cancer without working out extremely carefully the budget implications and cost-effectiveness of the drug.
Doctors know patients with atrial fibrillation are at a higher risk of having a stroke, and now a new study finds that integrating two separate clinical risk score models helps clinicians more accurately assess the stroke risk of patients with Afib.
› Verified 2 days ago
Dr. Wouhabe M Bancheno, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2041 Georgia Ave Nw Ste 3400, Washington, DC 20060 Phone: 202-865-6100 | |
Roopa Dhatt, Hospitalist Medicare: Medicare Enrolled Practice Location: 5255 Loughboro Rd Nw, Washington, DC 20016 Phone: 202-537-5452 | |
Caitlin Mingey, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2150 Pennsylvania Ave Nw, The Gw Medical Faculty Associates, Washington, DC 20037 Phone: 202-741-3000 | |
Melanie Anspacher, MD Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-4974 Fax: 202-476-3732 | |
Dr. Christopher Gibson, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Suite 2a, Washington, DC 20010 Phone: 202-877-0393 | |
Dr. Debralee B. Frederick, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 430 Galloway St Ne Ste A, Washington, DC 20011 Phone: 202-350-1546 Fax: 202-983-5497 | |
Stephen Overcash, Hospitalist Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-3670 Fax: 202-476-4741 |